Ping Tang
Concepts (285)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Breast Neoplasms | 17 | 2001 | 185 |
Why?
| Carcinoma, Intraductal, Noninfiltrating | 9 | 2001 | 19 |
Why?
| Carcinoma, Squamous Cell | 17 | 2003 | 111 |
Why?
| Carcinoma, Ductal, Breast | 6 | 2003 | 24 |
Why?
| Head and Neck Neoplasms | 6 | 2003 | 47 |
Why?
| Tumor Markers, Biological | 9 | 2001 | 112 |
Why?
| Thyroid Neoplasms | 6 | 2004 | 43 |
Why?
| Hypopharyngeal Neoplasms | 6 | 2005 | 1 |
Why?
| Immunohistochemistry | 13 | 2001 | 355 |
Why?
| Neck Dissection | 8 | 2003 | 10 |
Why?
| Laryngeal Neoplasms | 6 | 2004 | 9 |
Why?
| Receptors, Progesterone | 6 | 2006 | 28 |
Why?
| Carcinoma | 4 | 2008 | 109 |
Why?
| Prognosis | 20 | 2004 | 388 |
Why?
| Lymph Nodes | 6 | 2004 | 106 |
Why?
| Female | 46 | 2001 | 1643 |
Why?
| Lymphatic Metastasis | 13 | 2003 | 77 |
Why?
| Retrospective Studies | 24 | 2003 | 653 |
Why?
| Survival Rate | 17 | 2003 | 250 |
Why?
| Humans | 62 | 1985 | 1856 |
Why?
| Laryngectomy | 5 | 2004 | 4 |
Why?
| Middle Aged | 33 | 2003 | 1161 |
Why?
| Neoplasm Recurrence, Local | 9 | 2003 | 118 |
Why?
| Receptor, erbB-2 | 7 | 1994 | 25 |
Why?
| Adenovirus E1A Proteins | 2 | 2003 | 4 |
Why?
| Nasopharyngeal Neoplasms | 3 | 1985 | 6 |
Why?
| Aged | 26 | 2003 | 988 |
Why?
| Adult | 29 | 2003 | 1317 |
Why?
| Tumor Necrosis Factor-alpha | 5 | 1994 | 210 |
Why?
| Receptors, Estrogen | 5 | 2008 | 44 |
Why?
| Keratins | 3 | 2003 | 27 |
Why?
| Carcinoma, Mucoepidermoid | 1 | 2010 | 3 |
Why?
| Ligation | 1 | 2010 | 29 |
Why?
| Postoperative Hemorrhage | 1 | 2010 | 19 |
Why?
| Gene Expression Profiling | 2 | 2009 | 138 |
Why?
| Larynx | 2 | 2005 | 17 |
Why?
| Pathology | 1 | 2009 | 25 |
Why?
| Mastectomy, Segmental | 2 | 2003 | 16 |
Why?
| Paget's Disease, Mammary | 1 | 2009 | 1 |
Why?
| Carcinoma, Neuroendocrine | 1 | 2008 | 9 |
Why?
| Carcinoma, Small Cell | 1 | 2008 | 20 |
Why?
| Transforming Growth Factor alpha | 2 | 1997 | 12 |
Why?
| Male | 29 | 2001 | 1553 |
Why?
| Tongue Neoplasms | 2 | 2003 | 6 |
Why?
| Protein Precursors | 3 | 1995 | 48 |
Why?
| Cell Transformation, Neoplastic | 2 | 1985 | 86 |
Why?
| Neoplasm Proteins | 2 | 2006 | 110 |
Why?
| Combined Modality Therapy | 13 | 2004 | 219 |
Why?
| Mediastinal Neoplasms | 1 | 2007 | 21 |
Why?
| Neoplasms, Multiple Primary | 2 | 2003 | 39 |
Why?
| Genes, erbB-2 | 2 | 2003 | 9 |
Why?
| Receptor, Epidermal Growth Factor | 4 | 1997 | 54 |
Why?
| Surgical Procedures, Elective | 1 | 2006 | 31 |
Why?
| Tracheal Neoplasms | 1 | 2004 | 4 |
Why?
| Brain Neoplasms | 2 | 1997 | 116 |
Why?
| Neoplasm Staging | 9 | 2005 | 125 |
Why?
| Adenocarcinoma, Follicular | 1 | 2004 | 5 |
Why?
| Helicobacter Infections | 1 | 2004 | 10 |
Why?
| Gene Therapy | 2 | 2003 | 89 |
Why?
| Helicobacter pylori | 1 | 2004 | 10 |
Why?
| Gastric Mucosa | 1 | 2004 | 18 |
Why?
| Esophagitis | 1 | 2004 | 11 |
Why?
| Choristoma | 1 | 2004 | 20 |
Why?
| Gene Expression Regulation, Neoplastic | 3 | 1999 | 126 |
Why?
| Esophageal Diseases | 1 | 2004 | 10 |
Why?
| Aged, 80 and over | 11 | 2003 | 599 |
Why?
| Receptors, Androgen | 1 | 2008 | 29 |
Why?
| Cystadenoma, Mucinous | 1 | 2003 | 1 |
Why?
| Barrett Esophagus | 1 | 2004 | 14 |
Why?
| Pancreas | 1 | 2004 | 46 |
Why?
| Adenocarcinoma | 3 | 1986 | 167 |
Why?
| Carcinoma, Lobular | 1 | 2003 | 16 |
Why?
| Carcinoma, Adenoid Cystic | 3 | 2004 | 7 |
Why?
| Teratoma | 1 | 2003 | 23 |
Why?
| Adolescent | 10 | 2003 | 891 |
Why?
| Colon | 1 | 2003 | 44 |
Why?
| Ovarian Neoplasms | 1 | 2003 | 64 |
Why?
| Neoplasm Invasiveness | 4 | 2001 | 105 |
Why?
| Carcinoma in Situ | 1 | 2001 | 26 |
Why?
| Mesothelioma | 1 | 2001 | 22 |
Why?
| Cell Division | 2 | 1999 | 273 |
Why?
| Lung Neoplasms | 3 | 1986 | 159 |
Why?
| China | 2 | 2009 | 34 |
Why?
| Young Adult | 5 | 2007 | 380 |
Why?
| Treatment Outcome | 7 | 2003 | 661 |
Why?
| Oligodeoxyribonucleotides, Antisense | 1 | 1999 | 9 |
Why?
| Lipoproteins | 2 | 2009 | 52 |
Why?
| Poly(ADP-ribose) Polymerases | 2 | 1994 | 21 |
Why?
| Carcinoma, Papillary | 2 | 2006 | 16 |
Why?
| Lymph Node Excision | 3 | 2005 | 30 |
Why?
| Protein Processing, Post-Translational | 2 | 1995 | 78 |
Why?
| Receptors, Transforming Growth Factor beta | 1 | 1997 | 12 |
Why?
| Glioma | 1 | 1999 | 51 |
Why?
| Glottis | 3 | 2004 | 4 |
Why?
| Epidermal Growth Factor | 1 | 1997 | 51 |
Why?
| Estrogen Receptor alpha | 2 | 2006 | 20 |
Why?
| Follow-Up Studies | 5 | 2004 | 553 |
Why?
| Trans-Activators | 2 | 2009 | 113 |
Why?
| Stromal Cells | 2 | 2003 | 41 |
Why?
| HSP70 Heat-Shock Proteins | 1 | 1995 | 27 |
Why?
| Superoxide Dismutase | 1 | 1995 | 46 |
Why?
| Carrier Proteins | 2 | 2009 | 177 |
Why?
| Tumor Suppressor Proteins | 2 | 1998 | 51 |
Why?
| Adenosine Diphosphate Ribose | 1 | 1994 | 10 |
Why?
| Tissue Array Analysis | 3 | 2007 | 27 |
Why?
| Oncogenes | 1 | 1994 | 24 |
Why?
| Membrane Proteins | 2 | 2007 | 233 |
Why?
| Enzyme Inhibitors | 1 | 1995 | 216 |
Why?
| Mice, Nude | 2 | 1999 | 72 |
Why?
| RNA | 1 | 1995 | 126 |
Why?
| Tumor Burden | 1 | 2011 | 12 |
Why?
| Ki-67 Antigen | 1 | 2011 | 20 |
Why?
| Animals | 12 | 1985 | 1031 |
Why?
| Microscopy, Electron | 2 | 2001 | 178 |
Why?
| Maxillary Sinus Neoplasms | 1 | 2010 | 4 |
Why?
| Tumor Cells, Cultured | 4 | 1994 | 233 |
Why?
| Child | 4 | 2004 | 749 |
Why?
| Hemangiosarcoma | 1 | 2009 | 8 |
Why?
| Carotid Artery, Common | 1 | 2010 | 23 |
Why?
| Axilla | 1 | 2009 | 16 |
Why?
| Neck | 2 | 2006 | 31 |
Why?
| Paranasal Sinus Neoplasms | 1 | 2009 | 8 |
Why?
| Salivary Glands, Minor | 1 | 2009 | 2 |
Why?
| Salivary Gland Neoplasms | 1 | 2009 | 3 |
Why?
| Thyroidectomy | 2 | 2004 | 21 |
Why?
| Nipples | 1 | 2009 | 3 |
Why?
| Bone Neoplasms | 1 | 2011 | 83 |
Why?
| Mice | 6 | 1985 | 623 |
Why?
| Neoplasms, Radiation-Induced | 1 | 2009 | 31 |
Why?
| Immunophenotyping | 1 | 2009 | 66 |
Why?
| Microscopy, Polarization | 1 | 2008 | 5 |
Why?
| Drug Delivery Systems | 1 | 2009 | 55 |
Why?
| Survival Analysis | 1 | 2010 | 205 |
Why?
| Breast | 1 | 2008 | 40 |
Why?
| Neoplasms, Second Primary | 1 | 2009 | 31 |
Why?
| Sequence Deletion | 3 | 1995 | 88 |
Why?
| Age Factors | 1 | 2011 | 480 |
Why?
| Molecular Sequence Data | 4 | 1995 | 404 |
Why?
| Terminology as Topic | 1 | 2008 | 81 |
Why?
| Cystadenoma, Papillary | 1 | 2006 | 3 |
Why?
| Base Sequence | 3 | 1995 | 371 |
Why?
| Pharyngectomy | 1 | 2006 | 1 |
Why?
| Blood Proteins | 1 | 2007 | 71 |
Why?
| Image Interpretation, Computer-Assisted | 1 | 2008 | 47 |
Why?
| Mammary Neoplasms, Experimental | 1 | 2008 | 37 |
Why?
| Radiotherapy, Adjuvant | 1 | 2006 | 49 |
Why?
| Oncogene Proteins v-erbB | 1 | 2006 | 5 |
Why?
| Collagen | 1 | 2008 | 118 |
Why?
| Mammary Glands, Human | 1 | 2006 | 7 |
Why?
| Immunoassay | 1 | 2006 | 32 |
Why?
| Postoperative Complications | 1 | 2011 | 305 |
Why?
| Phenotype | 1 | 2009 | 303 |
Why?
| Radiotherapy Dosage | 1 | 2006 | 55 |
Why?
| Disease Progression | 1 | 2008 | 244 |
Why?
| Benzamides | 2 | 1994 | 11 |
Why?
| Niacinamide | 2 | 1994 | 8 |
Why?
| Protein Conformation | 2 | 1996 | 123 |
Why?
| Proportional Hazards Models | 1 | 2006 | 123 |
Why?
| Palatal Neoplasms | 1 | 2004 | 1 |
Why?
| Chi-Square Distribution | 1 | 2006 | 179 |
Why?
| Cytokines | 1 | 2009 | 207 |
Why?
| Esthesioneuroblastoma, Olfactory | 1 | 2004 | 3 |
Why?
| Nasal Cavity | 1 | 2004 | 12 |
Why?
| Parietal Cells, Gastric | 1 | 2004 | 2 |
Why?
| Pyloric Antrum | 1 | 2004 | 4 |
Why?
| Nose Neoplasms | 1 | 2004 | 12 |
Why?
| Gastritis | 1 | 2004 | 8 |
Why?
| Biological Markers | 1 | 2007 | 262 |
Why?
| Eosinophilia | 1 | 2004 | 24 |
Why?
| Bleomycin | 1 | 2003 | 28 |
Why?
| Antibiotics, Antineoplastic | 1 | 2003 | 35 |
Why?
| Neoplasm Transplantation | 1 | 2003 | 67 |
Why?
| Genes, p53 | 1 | 2003 | 43 |
Why?
| Radiation Tolerance | 1 | 2003 | 37 |
Why?
| Keratin-7 | 1 | 2003 | 5 |
Why?
| Keratin-20 | 1 | 2003 | 4 |
Why?
| Recombinant Proteins | 2 | 1996 | 290 |
Why?
| Antineoplastic Agents | 1 | 2009 | 190 |
Why?
| Intermediate Filament Proteins | 1 | 2003 | 17 |
Why?
| Disease-Free Survival | 3 | 2005 | 102 |
Why?
| Biopsy | 1 | 2004 | 207 |
Why?
| Heart Transplantation | 1 | 2003 | 44 |
Why?
| Heart Defects, Congenital | 1 | 2003 | 55 |
Why?
| Staining and Labeling | 1 | 2003 | 101 |
Why?
| Epithelioid Cells | 1 | 2001 | 1 |
Why?
| Pleura | 1 | 2001 | 18 |
Why?
| Microvilli | 1 | 2001 | 15 |
Why?
| Pleural Effusion, Malignant | 1 | 2001 | 10 |
Why?
| Adipose Tissue | 1 | 2003 | 80 |
Why?
| Mice, Inbred BALB C | 1 | 2003 | 176 |
Why?
| Stem Cells | 1 | 2006 | 107 |
Why?
| Pleural Neoplasms | 1 | 2001 | 18 |
Why?
| Basement Membrane | 1 | 2001 | 31 |
Why?
| Neoplasm Metastasis | 3 | 2004 | 112 |
Why?
| Gene Expression | 3 | 1994 | 291 |
Why?
| Transfection | 1 | 2003 | 237 |
Why?
| Extracellular Matrix | 1 | 2001 | 79 |
Why?
| Transplantation, Heterologous | 1 | 1999 | 57 |
Why?
| RNA, Messenger | 3 | 1995 | 394 |
Why?
| Clone Cells | 1 | 1999 | 92 |
Why?
| Phosphoric Monoester Hydrolases | 1 | 1998 | 24 |
Why?
| Structure-Activity Relationship | 2 | 1995 | 124 |
Why?
| Diagnosis, Differential | 1 | 2001 | 402 |
Why?
| Glioblastoma | 1 | 1998 | 44 |
Why?
| Down-Regulation | 2 | 2009 | 150 |
Why?
| Protein Biosynthesis | 1 | 1999 | 113 |
Why?
| Cell Line, Tumor | 2 | 2008 | 208 |
Why?
| Proto-Oncogene Proteins | 1 | 1998 | 113 |
Why?
| Cross-Linking Reagents | 1 | 1996 | 38 |
Why?
| Protein-Serine-Threonine Kinases | 1 | 1998 | 105 |
Why?
| Cytotoxicity, Immunologic | 1 | 1996 | 54 |
Why?
| Protein Sorting Signals | 1 | 1995 | 19 |
Why?
| Lasers | 2 | 1985 | 35 |
Why?
| Amino Acid Sequence | 2 | 1995 | 319 |
Why?
| Drug Resistance | 1 | 1995 | 83 |
Why?
| Receptors, Tumor Necrosis Factor | 1 | 1996 | 67 |
Why?
| Mutagenesis, Site-Directed | 1 | 1996 | 126 |
Why?
| Transcription, Genetic | 1 | 1999 | 253 |
Why?
| Cell Line | 3 | 1985 | 375 |
Why?
| Dactinomycin | 1 | 1994 | 40 |
Why?
| Models, Molecular | 1 | 1996 | 102 |
Why?
| Monocytes | 1 | 1996 | 124 |
Why?
| Oncogene Proteins, Viral | 1 | 1994 | 29 |
Why?
| Cell Survival | 2 | 1985 | 229 |
Why?
| Apoptosis | 1 | 1998 | 265 |
Why?
| Chromogranin A | 1 | 2011 | 8 |
Why?
| Phosphopyruvate Hydratase | 1 | 2011 | 24 |
Why?
| Calcitonin | 1 | 2011 | 23 |
Why?
| Models, Biological | 1 | 1996 | 410 |
Why?
| Mutation | 1 | 1996 | 340 |
Why?
| Antibody Specificity | 1 | 2009 | 71 |
Why?
| Lost to Follow-Up | 1 | 2009 | 1 |
Why?
| Dogs | 2 | 1995 | 159 |
Why?
| Tissue Embedding | 1 | 2008 | 1 |
Why?
| Microtomy | 1 | 2008 | 7 |
Why?
| Temperature | 1 | 2008 | 137 |
Why?
| Laryngeal Mucosa | 1 | 2007 | 2 |
Why?
| Mitoxantrone | 1 | 1986 | 9 |
Why?
| Neoplasms, Glandular and Epithelial | 1 | 2006 | 4 |
Why?
| Spermatocele | 1 | 2006 | 4 |
Why?
| von Hippel-Lindau Disease | 1 | 2006 | 10 |
Why?
| Stomach Neoplasms | 1 | 1986 | 28 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 243 |
Why?
| Carcinoma, Hepatocellular | 1 | 1986 | 53 |
Why?
| Hematoporphyrins | 1 | 1985 | 6 |
Why?
| Hypopharynx | 1 | 2005 | 2 |
Why?
| Matched-Pair Analysis | 1 | 2005 | 17 |
Why?
| Preoperative Care | 1 | 2006 | 93 |
Why?
| Liver Neoplasms | 1 | 1986 | 97 |
Why?
| Radiation-Sensitizing Agents | 1 | 1985 | 29 |
Why?
| Palate | 1 | 2004 | 10 |
Why?
| Salvage Therapy | 1 | 2004 | 37 |
Why?
| Vena Cava, Superior | 1 | 2003 | 11 |
Why?
| Anastomosis, Surgical | 1 | 2003 | 45 |
Why?
| Ventricular Function | 1 | 2003 | 23 |
Why?
| Coronary Circulation | 1 | 2003 | 41 |
Why?
| Pulmonary Artery | 1 | 2003 | 58 |
Why?
| Feasibility Studies | 1 | 2003 | 144 |
Why?
| Aorta | 1 | 2003 | 69 |
Why?
| Hemodynamics | 1 | 2003 | 131 |
Why?
| Quality of Life | 1 | 2004 | 188 |
Why?
| PTEN Phosphohydrolase | 1 | 1998 | 14 |
Why?
| Transgenes | 1 | 1998 | 56 |
Why?
| Questionnaires | 1 | 2004 | 360 |
Why?
| Genes, Tumor Suppressor | 1 | 1998 | 37 |
Why?
| Adenoviridae | 1 | 1998 | 60 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 1998 | 58 |
Why?
| Enzyme Activation | 1 | 1998 | 177 |
Why?
| Endoplasmic Reticulum, Rough | 1 | 1995 | 1 |
Why?
| Cell-Free System | 1 | 1995 | 34 |
Why?
| Ions | 1 | 1995 | 29 |
Why?
| Phosphorylation | 1 | 1998 | 224 |
Why?
| Cercopithecus aethiops | 1 | 1995 | 67 |
Why?
| Biological Transport | 1 | 1995 | 129 |
Why?
| Cells, Cultured | 2 | 1985 | 447 |
Why?
| Cell Membrane | 1 | 1995 | 170 |
Why?
| Fibroblasts | 2 | 1985 | 179 |
Why?
| Signal Transduction | 1 | 1998 | 313 |
Why?
| Mitotic Index | 1 | 1986 | 9 |
Why?
| Tumor Stem Cell Assay | 1 | 1986 | 21 |
Why?
| Neon | 1 | 1985 | 2 |
Why?
| Helium | 1 | 1985 | 8 |
Why?
| Swine | 1 | 1985 | 95 |
Why?
| Fetus | 1 | 1985 | 105 |
Why?
| DNA | 1 | 1985 | 262 |
Why?
|
|
Tang's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
